Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
Add more filters

Country/Region as subject
Publication year range
1.
Euro Surveill ; 24(13)2019 Mar.
Article in English | MEDLINE | ID: mdl-30940318

ABSTRACT

BackgroundCampylobacteriosis is the most commonly reported food-borne infection in the European Union, with an annual number of cases estimated at around 9 million. In many countries, campylobacteriosis has a striking seasonal peak during early/mid-summer. In the early 2000s, several publications reported on campylobacteriosis seasonality across Europe and associations with temperature and precipitation. Subsequently, many European countries have introduced new measures against this food-borne disease.AimTo examine how the seasonality of campylobacteriosis varied across Europe from 2008-16, to explore associations with temperature and precipitation, and to compare these results with previous studies. We also sought to assess the utility of the European Surveillance System TESSy for cross-European seasonal analysis of campylobacteriosis.MethodsWard's Minimum Variance Clustering was used to group countries with similar seasonal patterns of campylobacteriosis. A two-stage multivariate meta-analysis methodology was used to explore associations with temperature and precipitation.ResultsNordic countries had a pronounced seasonal campylobacteriosis peak in mid- to late summer (weeks 29-32), while most other European countries had a less pronounced peak earlier in the year. The United Kingdom, Ireland, Hungary and Slovakia had a slightly earlier peak (week 24). Campylobacteriosis cases were positively associated with temperature and, to a lesser degree, precipitation.ConclusionAcross Europe, the strength and timing of campylobacteriosis peaks have remained similar to those observed previously. In addition, TESSy is a useful resource for cross-European seasonal analysis of infectious diseases such as campylobacteriosis, but its utility depends upon each country's reporting infrastructure.


Subject(s)
Campylobacter Infections/epidemiology , Campylobacter/isolation & purification , Disease Outbreaks , Epidemiological Monitoring , Europe/epidemiology , Humans , Incidence , Seasons , Sentinel Surveillance , Temperature
2.
Epidemiol Infect ; 143(16): 3468-74, 2015 Dec.
Article in English | MEDLINE | ID: mdl-25906969

ABSTRACT

Early investigation of travel-related cases in an outbreak of an emerging infectious disease can provide useful information to epidemiologists to characterize the exposure, while they may differ in demographic profiles from cases reported in the country where the outbreak has occurred. During the spring 2011 E. coli outbreak in Germany, we proposed a methodological approach to collect a minimal set of demographic and clinical data that are relatively easy to obtain and available at an early stage of an outbreak investigation. Ninety-eight STEC O104 travel-related cases were reported in a survey by seven EU countries, Switzerland, Canada and the USA. We found a mean incubation period (n = 50) of 8·5 days, which confirmed previous estimations communicated by the Robert Koch Institute. No significant association was found between the duration of the incubation period and possible demographic and clinical factors, although the older the age, the shorter the incubation period that was observed. Such approach and observations are informative for further investigations of outbreaks of enterohaemorrhagic E. coli or other emerging infectious diseases.


Subject(s)
Disease Outbreaks , Escherichia coli Infections/epidemiology , Shiga-Toxigenic Escherichia coli/isolation & purification , Travel , Adult , Aged , Canada/epidemiology , Female , Germany/epidemiology , Humans , Infectious Disease Incubation Period , Male , Middle Aged , Serogroup , Shiga-Toxigenic Escherichia coli/classification , Switzerland/epidemiology , Time Factors , United States/epidemiology
3.
Euro Surveill ; 20(29): 21193, 2015 Jul 23.
Article in English | MEDLINE | ID: mdl-26227371

ABSTRACT

Epidemiological investigations of outbreaks of hepatitis A virus (HAV) and norovirus (NoV) infections in the European Union/European Economic Area (EU/EEA) in the last five years have highlighted frozen berries as a vehicle of infection. Given the increasing berry consumption in the EU over the last decades, we undertook a review of the existing evidence to assess the potential scale of threat associated with this product. We searched the literature and four restricted-access online platforms for outbreak/contamination events associated with consumption of frozen berries. We performed an evaluation of the sources to identify areas for improvement. The review revealed 32 independent events (i.e. outbreak, food contamination) in the period 1983­2013, of which 26 were reported after 2004. The identified pathogens were NoV, HAV and Shigella sonnei. NoV was the most common and implicated in 27 events with over 15,000 cases reported. A capture­recapture analysis was performed including three overlapping sources for the period 2005­2013. The study estimated that the event-ascertainment was 62%. Consumption of frozen berries is associated with increasing reports of NoV and HAV outbreaks and contamination events, particularly after 2003. A review of the risks associated with this product is required to inform future prevention strategies. Better integration of the available communication platforms and databases should be sought at EU/EEA level to improve monitoring, prevention and control of food-borne-related events.


Subject(s)
Caliciviridae Infections/epidemiology , Disease Outbreaks , Dysentery, Bacillary/epidemiology , Food Contamination/analysis , Foodborne Diseases/epidemiology , Frozen Foods/microbiology , Fruit/microbiology , Hepatitis A virus/isolation & purification , Hepatitis A/epidemiology , Adolescent , Adult , Caliciviridae Infections/diagnosis , Child, Preschool , Dysentery, Bacillary/diagnosis , Epidemiologic Studies , Europe/epidemiology , European Union , Female , Foodborne Diseases/diagnosis , Foodborne Diseases/microbiology , Frozen Foods/poisoning , Fruit/poisoning , Hepatitis A/diagnosis , Humans , Male , Middle Aged , Norovirus/isolation & purification , Population Surveillance , Shigella sonnei/isolation & purification , Surveys and Questionnaires
4.
Euro Surveill ; 20(29): 21192, 2015 Jul 23.
Article in English | MEDLINE | ID: mdl-26227370

ABSTRACT

In May 2013, Italy declared a national outbreak of hepatitis A, which also affected several foreign tourists who had recently visited the country. Molecular investigations identified some cases as infected with an identical strain of hepatitis A virus subgenotype IA. After additional European Union/European Economic Area (EU/EEA) countries reported locally acquired and travel-related cases associated with the same outbreak, an international outbreak investigation team was convened, a European outbreak case definition was issued and harmonisation of the national epidemiological and microbiological investigations was encouraged. From January 2013 to August 2014, 1,589 hepatitis A cases were reported associated with the multistate outbreak; 1,102 (70%) of the cases were hospitalised for a median time of six days; two related deaths were reported. Epidemiological and microbiological investigations implicated mixed frozen berries as the vehicle of infection of the outbreak. In order to control the spread of the outbreak, suspected or contaminated food batches were recalled, the public was recommended to heat-treat berries, and post-exposure prophylaxis of contacts was performed. The outbreak highlighted how large food-borne hepatitis A outbreaks may affect the increasingly susceptible EU/EEA general population and how, with the growing international food trade, frozen berries are a potential high-risk food.


Subject(s)
Disease Outbreaks , Food Contamination , Foodborne Diseases/epidemiology , Fruit/poisoning , Hepatitis A virus/genetics , Hepatitis A/epidemiology , Adolescent , Adult , Child, Preschool , Contact Tracing , Epidemiologic Studies , Europe/epidemiology , European Union , Female , Foodborne Diseases/diagnosis , Foodborne Diseases/virology , Frozen Foods/poisoning , Frozen Foods/virology , Fruit/virology , Hepatitis A/virology , Hepatitis A virus/isolation & purification , Humans , Male , Middle Aged , Surveys and Questionnaires
5.
Euro Surveill ; 19(19)2014 May 15.
Article in English | MEDLINE | ID: mdl-24852954

ABSTRACT

Between August 2011 and January 2013, an outbreak of Salmonella enterica serovar Stanley (S. Stanley) infections affected 10 European Union (EU) countries, with a total of 710 cases recorded. Following an urgent inquiry in the Epidemic Intelligence Information System for food- and waterborne diseases (EPIS-FWD) on 29 June 2012, an international investigation was initiated including EU and national agencies for public health, veterinary health and food safety. Two of three local outbreak investigations undertaken by affected countries in 2012 identified turkey meat as a vehicle of infection. Furthermore, routine EU monitoring of animal sources showed that over 95% (n=298) of the 311 S. Stanley isolates reported from animal sampling in 2011 originated from the turkey food production chain. In 2004­10, none had this origin. Pulsed-field gel electrophoresis (PFGE) profile analysis of outbreak isolates and historical S. Stanley human isolates revealed that the outbreak isolates had a novel PFGE profile that emerged in Europe in 2011. An indistinguishable PFGE profile was identified in 346 of 464 human, food, feed, environmental and animal isolates from 16 EU countries: 102 of 112 non-human isolates tested were from the turkey production chain. On the basis of epidemiological and microbiological evidence, turkey meat was considered the primary source of human infection, following contamination early in the animal production chain.


Subject(s)
Disease Outbreaks , Food Microbiology , Meat/microbiology , Salmonella Infections/epidemiology , Salmonella/isolation & purification , Turkeys/microbiology , Adult , Animals , Cluster Analysis , Communicable Disease Control , Europe/epidemiology , European Union , Female , Humans , Incidence , Male , Molecular Typing , Population Surveillance , Salmonella/classification , Salmonella Infections/microbiology , Salmonella Infections/prevention & control , Salmonella Infections/transmission , Serotyping
6.
Epidemiol Infect ; 141(8): 1640-6, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23068603

ABSTRACT

In 2010, 7/44 (16%) reported foodborne outbreaks in Finland were linked with raw beetroot consumption. We reviewed data from the national outbreak registry in order to hypothesize the aetiology of illness and to prevent further outbreaks. In the seven outbreaks, 124 cases among 623 respondents were identified. Consumption of raw beetroot was strongly associated with gastrointestinal illness (relative risk 8∙99, 95% confidence interval 6∙06-13∙35). The illness was characterized by sudden onset of gastrointestinal symptoms; the median incubation time was 40 min and duration of illness 5 h. No common foodborne pathogens or toxins were found in either clinical or beetroot samples, but all tested beetroot samples were of poor quality according to total bacterial counts. Beta-haemolytic Pseudomonas fluorescens was detected in several beetroot samples but its effect on human health is unknown. No outbreaks were reported after the Finnish Food Safety Authority Evira advised against serving raw beetroot in institutional canteens.


Subject(s)
Beta vulgaris/poisoning , Disease Outbreaks , Food Microbiology , Foodborne Diseases/epidemiology , Gastroenteritis/epidemiology , Adolescent , Adult , Aged , Beta vulgaris/microbiology , Cohort Studies , Female , Finland/epidemiology , Foodborne Diseases/microbiology , Gastroenteritis/microbiology , Humans , Male , Middle Aged , Retrospective Studies , Seasons , Young Adult
7.
Euro Surveill ; 18(25)2013 Jun 20.
Article in English | MEDLINE | ID: mdl-23806297

ABSTRACT

A hybrid strain of enteroaggregative and Shiga toxin 2-producing Escherichia coli (EAEC-STEC) serotype O104:H4 strain caused a large outbreak of haemolytic uraemic syndrome and bloody diarrhoea in 2011 in Europe. Two surveys were performed in the European Union (EU) and European Economic Area (EEA) countries to assess their laboratory capabilities to detect and characterise this previously uncommon STEC strain. Prior to the outbreak, 11 of the 32 countries in this survey had capacity at national reference laboratory (NRL) level for epidemic case confirmation according to the EU definition. During the outbreak, at primary diagnostic level, nine countries reported that clinical microbiology laboratories routinely used Shiga toxin detection assays suitable for diagnosis of infections with EAEC-STEC O104:H4, while 14 countries had NRL capacity to confirm epidemic cases. Six months after the outbreak, 22 countries reported NRL capacity to confirm such cases following initiatives taken by NRLs and the European Centre for Disease Prevention and Control (ECDC) Food- and Waterborne Disease and Zoonoses laboratory network. These data highlight the challenge of detection and confirmation of epidemic infections caused by atypical STEC strains and the benefits of coordinated EU laboratory networks to strengthen capabilities in response to a major outbreak.


Subject(s)
Escherichia coli Infections/epidemiology , Shiga-Toxigenic Escherichia coli/isolation & purification , Animals , Clinical Laboratory Techniques/methods , Developing Countries , Diarrhea/diagnosis , Diarrhea/epidemiology , Diarrhea/microbiology , Disease Outbreaks , Escherichia coli/isolation & purification , Escherichia coli Infections/diagnosis , Europe/epidemiology , European Union/statistics & numerical data , Feces/microbiology , Humans , Shiga Toxin 2/isolation & purification
8.
Euro Surveill ; 18(11): 20422, 2013 Mar 14.
Article in English | MEDLINE | ID: mdl-23517870

ABSTRACT

We describe the outbreak investigation associated with an unusual increase in Salmonella Goldcoast cases in Hungary observed in autumn 2009, which included descriptive and analytical epidemiological studies and microbiological and veterinary investigations. Sixty cases were identified between 1 January 2009 and 1 March 2010, 50 of them from late July 2009 to January 2010. Of 50 S. Goldcoast isolates, 44 showed an indistinguishable pulsed-field gel electrophoresis profile. We conducted a matched case-control study that indicated a statistically significant association between S. Goldcoast infection and the consumption of pork cheese. The majority of cases (seven of nine) reporting consumption of this product belonged to a single family cluster. After removing six cases of this cluster, pork cheese still showed an elevated but non-significant risk for being a case in the univariable analysis (Mantel-Haenszel odds ratio (MH OR): 3.87, 95% confidence interval (CI): 0.38-39.47). A single S. Goldcoast isolate was identified during routine veterinary surveillance activities in 2009 in minced beef from a butcher's shop, originating from an abattoir where also pigs were slaughtered. We conclude that the outbreak was probably due to multiple sources of contaminated meat, probably pork, released on the market over a period of several months in 2009.


Subject(s)
Foodborne Diseases/epidemiology , Health Knowledge, Attitudes, Practice , Salmonella Food Poisoning/epidemiology , Case-Control Studies , Cheese/microbiology , Disease Notification , Disease Outbreaks , Food Microbiology/standards , Foodborne Diseases/microbiology , Humans , Hungary/epidemiology , Meat Products/microbiology , Population Surveillance , Salmonella/classification , Salmonella/isolation & purification , Salmonella Food Poisoning/microbiology , Socioeconomic Factors , Surveys and Questionnaires , Vomiting/complications
9.
Euro Surveill ; 16(13)2011 Mar 31.
Article in English | MEDLINE | ID: mdl-21489375

ABSTRACT

We present a summary of the main findings of the latest report of the European Food Safety Authority and European Centre for Disease Prevention and Control on zoonoses, zoonotic agents and food-borne outbreaks in the European Union (EU), based on data from 2009. Zoonoses are prevalent and widely distributed across several countries in the EU. The most important highlight of this report was the continuous decrease of human salmonellosis since 2005, probably due to effective control programmes in livestock.


Subject(s)
Foodborne Diseases/epidemiology , Zoonoses/epidemiology , Animals , Bacterial Infections/epidemiology , European Union , Humans , Parasitic Diseases/epidemiology , Rabies/epidemiology
10.
Eur J Clin Microbiol Infect Dis ; 28(1): 17-20, 2009 Jan.
Article in English | MEDLINE | ID: mdl-18604573

ABSTRACT

The purpose of this study was to evaluate the overall performance of rapid antigen detection (RAD) in group A streptococcus (GAS) in Finland by using the results of external quality assurance (EQA) samples. We also compared the performance of laboratory professionals to that of nursing professionals. Around 22,800 EQA results among a total of 383 laboratories and physician's offices were analysed. Vocational data on the personnel who carried out the tests were available for 10,088 EQA samples, 7,428 of which were tested by laboratory technicians and 2,531 by nursing staff. The best overall performance was found with GAS-negative samples: 99% of the reports were correct. In contrast, the overall performance was only 76% when the samples were weakly positive for GAS antigen. The laboratory technicians performed statistically significantly better than the nursing staff, with both strongly positive (correct results 98.9% vs. 95.1%, respectively; p<0.001) and weakly positive (79.3% vs. 65.3%, respectively; p<0.001) samples. With negative samples, no difference in performance between the laboratory and nursing staff was found (99.5% vs. 99.0%, respectively). The professional skills of the person performing the RAD test for GAS have a major impact on the sensitivity of the test. Based on the results of this study, we suggest that EQA-like artificial specimens could be used as a tool to improve and validate the quality of RAD testing in individual testing sites.


Subject(s)
Antigens, Bacterial/analysis , Health Services Research , Point-of-Care Systems , Streptococcal Infections/diagnosis , Streptococcus pyogenes/isolation & purification , Diagnostic Errors/statistics & numerical data , Finland , Humans , Observer Variation , Sensitivity and Specificity , Streptococcal Infections/microbiology , Streptococcus pyogenes/immunology
13.
Int J Hyg Environ Health ; 203(4): 369-73, 2001 May.
Article in English | MEDLINE | ID: mdl-11434217

ABSTRACT

An outbreak of diarrhoeal disease in a modern mother-and-child health clinic prompted the health authorities to initiate a retrospective cohort study in order to assess the scope of the outbreak and to identify possible risk factors. The management of the clinic had been rather concerned because four similar outbreaks had occurred during the last two years. A total of 151 guests, i.e. mothers with their children, who had arrived some days before the peak of the outbreak for a three-week-stay and another 15 guests who had arrived earlier and had extended their stay were enrolled in the study which mainly focused on the possible role of treatment measures as risk factors. In addition, a total of 49 staff members were requested to provide information about symptoms, working area and attendance at work. Relevant data were available from 164 of 166 guests and 47 of 49 staff members (response rates 98.8% and 96.0%, respectively). The attack rate among guests was 44.0% (adults 27.0%, children 54.0%) and among staff 23.4%. The mean age of affected children (3.5 years) was significantly lower than that of those not affected (6.3 years). The main symptoms were diarrhoea and vomiting. The sudden start of the outbreak suggested a single source of infection which, however, remained unknown. Person-to-person transmission was supposed to be the cause of the following spread. No association between distinct treatment measures and the disease was proven by the cohort study. Norwalk-like viruses as well as astroviruses were detected by polymerase chain reaction in specimens taken from seven patients. No other enteropathogenic agents were found. Regarding the special conditions in a mother-and-child health clinic where social contacts among guests are much more frequent and intensive than among patients in a "normal" hospital, measures to prevent the spread of gastrointestinal infections should concentrate on early recognition and isolation of symptomatic individuals. Guests and staff members should be instructed to keep to the rules of personal hygiene, especially handwashing. If disinfection is required, it should be virucidal.


Subject(s)
Caliciviridae Infections/epidemiology , Disease Outbreaks , Gastroenteritis/epidemiology , Maternal-Child Health Centers , Adolescent , Caliciviridae Infections/prevention & control , Caliciviridae Infections/transmission , Child , Child, Preschool , Cohort Studies , Disease Outbreaks/prevention & control , Female , Gastroenteritis/prevention & control , Gastroenteritis/virology , Germany/epidemiology , Humans , Infant , Mamastrovirus/isolation & purification , Mothers , Norwalk virus/isolation & purification , Retrospective Studies
14.
Euro Surveill ; 8(11): 219-22, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14684883

ABSTRACT

Over 700 participants from 54 countries attended the eleventh Campylobacter, Helicobacter and Related Organisms (CHRO) meeting in September 2001. This meeting was an opportunity to update and better understand the microbiological and epidemiological complexities of Campylobacter. The mechanism of pathogenesis of this bacteria is not yet fully understood and important progress was made in the microbiological characterisation. The availability of over 100 different strain characteristics from various locations all over Europe, brought together by Campynet, is an invaluable tool for achieving this aim. There is increasing evidence to suggest that different risk factors exist for different species of Campylobacter. The link between antibiotic use in farm animals and increased resistance to some antimicrobials for humans still needs to be proved and some contradictory results reported on this issue.


Subject(s)
Campylobacter/classification , Campylobacter/pathogenicity , Helicobacter , Animal Diseases/drug therapy , Animal Diseases/epidemiology , Animals , Animals, Domestic/microbiology , Anti-Bacterial Agents/adverse effects , Anti-Bacterial Agents/therapeutic use , Campylobacter/drug effects , Campylobacter Infections/epidemiology , Drug Resistance, Bacterial/drug effects , Humans , Serotyping/classification
15.
Euro Surveill ; 8(11): 207-13, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14684880

ABSTRACT

Two surveys have been conducted on behalf of the Campylobacter Working Group with the aim of assessing the feasibility of a European network on human Campylobacter infections. The first survey, conducted in 18 countries, collected information about diagnostic methods used for surveillance purpose while the second one, conducted among 10 European countries, gathered data on diagnostic methods and procedures in primary laboratories. Seventeen of the 18 countries had a surveillance system for Campylobacter infections and 13 a national reference laboratory. The case definition used for the surveillance in all these countries included laboratory confirmation. No commonly applicable subtyping methods were applied. Concerning primary laboratories dealing with Campylobacter infections, only a few of them reported directly to the national level, and antimicrobial susceptibility testing was performed by about half of the laboratories. These surveys indicated that a basic infrastructure for a wide European Campylobacter surveillance exists.


Subject(s)
Campylobacter Infections/diagnosis , Campylobacter Infections/epidemiology , Campylobacter/isolation & purification , Anti-Bacterial Agents/metabolism , Anti-Bacterial Agents/therapeutic use , Campylobacter/classification , Campylobacter/drug effects , Campylobacter Infections/classification , Campylobacter Infections/drug therapy , Data Collection/methods , Drug Resistance, Bacterial , Europe/epidemiology , Feasibility Studies , Health Planning Guidelines , Humans , Laboratories/standards , Microbial Sensitivity Tests/classification , Microbial Sensitivity Tests/methods , Microbial Sensitivity Tests/trends , Population Surveillance/methods , Quality Assurance, Health Care/methods , Quality Assurance, Health Care/standards , Sentinel Surveillance , Surveys and Questionnaires
SELECTION OF CITATIONS
SEARCH DETAIL